Spain· ES:05331002
NEUPRO 2 MG/24 H PARCHE TRANSDERMICO
A medicinal product containing rotigotina, registered in Spain by Ucb Pharma.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rotigotina
- Manufacturer
- Ucb Pharma
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo65393528EUR 37.47
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rotigotina in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEUPROUCB Pharma SA, Brusel
- BelgiumLeganto 2 mg/24 hUCB
- ItalyNEUPROUCB PHARMA S.A.
- United StatesNeuproUCB, Inc.
- PolandNeuproUCB Pharma S.A.
- NetherlandsNeupro 2 mg/24 h pleister voor transdermaal gebruikUCB Pharma S.A.
- United KingdomNeupro 1mg/24hours transdermal patchesUCB Pharma Ltd
- FinlandKinparlevOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Kinparlev, Rotigotin Gebro
- Germany · Rotigotin Luye, Rotigotin Neuraxpharm
- Denmark · Kinparlev, Rotigotine Medical Valley
- Finland · Kinparlev, Rotigotine Medical Valley
- France · Rotigotine Arrow
- Greece · Kinparlev
- Iceland · Neupro, Rotigotine Medical Valley
- Italy · Rotigotina Doc
- Liechtenstein · Neupro
- Luxembourg · Rotigotin Luye
- Netherlands · Rotigotine Medical Valley, Rotigotine Xiromed
- Norway · Kinparlev, Neupro
- Portugal · Kinparlev, Rotigotina Generis
- Romania · Kinparlev
- Sweden · Kinparlev, Rotigotine Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb896728-df24-4dec-b242-8349589c4be5 GET /v1/drugs/fb896728-df24-4dec-b242-8349589c4be5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1145570400000}",
"nregistro": "05331002",
"substance": "rotigotina"
}See everything about rotigotina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.